Skip to content
Application 076019
- Type
- ANDA
- Sponsor
- HOSPIRA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | DEFEROXAMINE MESYLATE | DEFEROXAMINE MESYLATE | INJECTABLE;INJECTION | 500MG/VIAL | No | No |
| 002 | DEFEROXAMINE MESYLATE | DEFEROXAMINE MESYLATE | INJECTABLE;INJECTION | 2GM/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0409-2336 | Deferoxamine Mesylate | Deferoxamine Mesylate | Hospira, Inc. | ANDA | Current |
| 0409-2336 | Deferoxamine Mesylate | Deferoxamine Mesylate | Hospira, Inc. | ANDA | Current |
| 0409-2336 | Deferoxamine Mesylate | Deferoxamine Mesylate | Hospira, Inc. | ANDA | Current |
| 0409-2336 | Deferoxamine Mesylate | Deferoxamine Mesylate | Hospira, Inc. | ANDA | Current |
| 0409-2336 | Deferoxamine Mesylate | Deferoxamine Mesylate | Hospira, Inc. | ANDA | Current |
| 0409-2337 | Deferoxamine Mesylate | Deferoxamine Mesylate | Hospira, Inc. | ANDA | Current |
| 0409-2337 | Deferoxamine Mesylate | Deferoxamine Mesylate | Hospira, Inc. | ANDA | Current |
| 0409-2337 | Deferoxamine Mesylate | Deferoxamine Mesylate | Hospira, Inc. | ANDA | Current |
| 0409-2337 | Deferoxamine Mesylate | Deferoxamine Mesylate | Hospira, Inc. | ANDA | Current |
| 0409-2337 | Deferoxamine Mesylate | Deferoxamine Mesylate | Hospira, Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 22527 | ORIG | 2006-04-20 |
| 31062 | ORIG | 2004-03-19 |